Sangamo Therapeutics - Chapter 11 DIP Terms

Sangamo Therapeutics obtained interim approval for a $30 million non-amortizing senior secured superpriority DIP term loan facility from Northridge ATM, LLC, with up to $10.5 million available upon entry of the interim order and the balance of the commitments (the full $30 million less amounts drawn at the interim stage) available upon entry of a final order, priced at 12% cash interest (plus 2% default interest) and maturing on the earliest of several events but no later than December 30, 2026, while carrying a 2% commitment fee and a 5% exit fee and affording the lender the right to credit bid up to the full amount of its DIP obligations in any sale of the collateral (whether under Section 363, a plan, or a chapter 7 sale). On July 23, 2026, Sangamo Therapeutics obtained interim approval for a $35 million non-amortizing senior secured superpriority replacement DIP term loan from Future Solution Investments, with up to $18 million available under the interim order and the balance upon final approval, bearing 9% cash interest, carrying no DIP fees and funding chapter 11 operations and repayment of the original DIP facility.

$30MM Northridge DIP Terms

Borrower / Guarantors

DIP Lender

DIP Commitments

Cash Collateral

Interest Rate

Fees

Maturity

Prepayments

Carve Out

Use of Proceeds

Conditions Precedent

Credit Bid

Avoidance Actions

Securities and Priorities

Limitations on Use of Proceeds, Cash Collateral, and Carve Out (Restricted Use)

Events of Default

Indemnification and Expense Reimbursement

Stipulations and Releases

Modification of Automatic Stay and Remedies

Waivers

Permitted Variance

$35MM Replacement DIP Terms

Borrower(s) / Guarantor(s)

Lender

DIP Commitments

Cash Collateral

Interest Rate

Fees and Expenses

Maturity

Voluntary and Mandatory Prepayments

Carve Out

Use of Proceeds

Original DIP Facility Repayment

Post-Sale Escrow

Credit Bid

Excluded Collateral

Securities and Priorities

Waivers

Budget and Permitted Variance

Conditions Precedent

Events of Default

Remedies

Limitations on Use

Good Faith and Section 364(e) Protection

Insurance and Maintenance of Collateral

Releases

Reporting and Access

Amendments

Governing Law and Jurisdiction

Final Hearing